The invention relates to a method for manufacturing inhaler articles (10). The method comprises providing a plurality of semifinished inhaler articles. Each inhaler article comprises a longitudinal axis, a proximal end, and an open distal end (16). The method comprises aligning the semifinished inhaler articles such that their longitudinal axes are arranged in parallel and the open distal ends of the semifinished inhaler articles are located at the exact same height with respect to a direction parallel to the longitudinal axes. The method comprises at least partially closing the distal ends of the aligned semifinished inhaler articles. The invention further relates to packages of inhaler articles with uniformly closed ends. The invention further relates to a holder for an apparatus for manufacturing inhaler articles. The invention further relates to an apparatus for manufacturing inhaler articles.

The present invention relates to a dispensing arrangement (1), or to an e-cigarette (100) containing such a dispensing arrangement, for treating a flow of vaporized liquid provided via a flow channel (3) of an e-cigarette, comprising a dispensing unit (10) for adding an additional composition into the flow of vaporized liquid of the e-cigarette, and a composition reservoir (2) for retaining the additional composition, wherein the dispensing unit is in communication with a composition reservoir and in communication with the flow channel, wherein the composition reservoir is arranged separately to the flow channel, and wherein the dispensing arrangement is adapted to temper the vaporized liquid and/or the additional composition to a temperature of below 40 C. or below 35 C. before adding the additional composition into the flow of vaporized liquid, as well as methods for the oral intake of compositions, particularly those comprising temperature-sensitive compounds or compounds insoluble in the liquid carrier, such as certain anti-aging compounds, by virtue of an e-cigarette comprising said dispensing arrangement. The present invention also relates to uses of said dispensing arrangement or of an e-cigarette comprising said dispensing arrangement for the oral intake of additional compositions comprising at least one anti-aging compound to a user.

The present disclosure relates to a novel flavoring agent, a flavoring agent composition, and an article including the same, and more particularly, to a flavoring agent as a compound that includes a moiety derived from a sugar compound and a moiety derived from a flavoring compound in a basic backbone and is pyrolyzed into a lactone compound, a sugar compound, and a flavoring compound upon pyrolysis, and a composition and an article including the same.

This invention discloses a kind of microburst-microcapsule designed for cigarettes and a smoking article with such microburst-microcapsules. Wherein the microburst-microcapsule is composed of a microcapsule wall and an aerosol generation material encapsulated by the microcapsule wall. The microburst-microcapsule can be filled in cigarette. When the cigarette lights, the high temperature generated from its combustion zone will vaporize the nearest aerosol generation materials packaged in the aforesaid microburst-microcapsule. The vapor pressure will cause the microcapsule wall burst. As a result, the aerosol from the aforesaid aerosol generation materials will vapor out of the microcapsule wall. Tobacco-free carbonaceous fuels or solid carbonaceous from high temperature vacuum destructive distillation of tobacco filament can be used as combustion materials for aforesaid cigarettes.

Compositions configured for oral use, the compositions including at least one active ingredient selected from caffeine, taurine, GABA, theanine, tryptophan, vitamin B6, vitamin B12, vitamin C, lemon balm extract, ginseng, citicoline, sunflower lecithin, or combinations thereof, are provided. The compositions include one or more fillers, including a sugar alcohol, and optionally, a lipid or binder. The compositions may be in chewable, tablet, or meltable forms.

A smokeless tobacco product or medicinal nicotine product including nicotine and acyl nornicotine. Preferably, the acyl nornicotine is selected from the group consisting of N-Pentanoylnornicotine, N-Hexanoylnornicotine, N-Heptanolynornicotine, N-Octanoylnornicotine, N-Nonanoylnornicotine, N-Decanoylnornicotine, N-Undecanoylnornicotine, and N-Dedecanoylnornicotine. Also disclosed are methods of making such products.

Compositions configured for oral use, the compositions including at least one active ingredient selected from caffeine, taurine, GABA, theanine, tryptophan, vitamin B6, vitamin B12, vitamin C, lemon balm extract, ginseng, citicoline, sunflower lecithin, or combinations thereof, are provided. The compositions include one or more fillers, including a sugar alcohol, and optionally, a lipid or binder. The compositions may be in chewable, tablet, or meltable forms.

A smokeless tobacco product or medicinal nicotine product including nicotine and acyl nornicotine. Preferably, the acyl nornicotine is selected from the group consisting of N-Pentanoylnornicotine, N-Hexanoylnornicotine, N-Heptanolynornicotine, N-Octanoylnornicotine, N-Nonanoylnornicotine, N-Decanoylnornicotine, N-Undecanoylnornicotine, and N-Dedecanoylnornicotine. Also disclosed are methods of making such products.

The present invention relates to compositions comprising a constituent, derivative or extract of cannabis in amorphous form. The invention also relates to products comprising such compositions and methods of manufacturing them.

An oral pouched product is disclosed, the oral pouched product includes a saliva permeable pouch, a non-tobacco pouch composition, the pouch composition includes heat-treated fibers, nicotine in an amount of 0.1-5.0% by weight of the pouch compositions, water in an amount 15-65% by weight of the pouch composition, at least one sugar alcohol, and less than 0.5% preservative by weight of the pouch composition. Also, a method for manufacturing an oral pouched product is disclosed.